Funds › AlphaCentric Advisors LLC
AlphaCentric Advisors LLC
13F for Q3 2026, filed Nov 3, 2026. 245 positions worth $112.6M.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Latest report
Q3 2026
filed Nov 3, 2026
Reported value
$112.6M
−$5.4M (4.6%) vs Q2 2026
Positions
245
259 in Q2 2026
Top 10 share
23.4%
of reported value
CheckedEach line's price per share is checked against other managers' reports of the same stock. Unit mix-ups are corrected. Reports no fix can rescue are left out.
Clean
prices match other managers' reports
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what are the biggest new, added, trimmed and exited positions of AlphaCentric Advisors LLC in the latest 13F quarter?
Using 13F.ai, how has AlphaCentric Advisors LLC's portfolio concentration changed over the last four quarters?
Using 13F.ai, which of AlphaCentric Advisors LLC's top holdings have also been bought by insiders recently?
Connect your AI · Plans and the 7-day free trial (card required)
Holdings, Q3 2026
Largest first. Common shares only; puts and calls are under All positions.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | iShares Tr Etf | 66,011 | $5.4M | 4.8% | +410% | 13F ↗ |
| 2 | GILD Gilead Sciences, Inc. | 21,278 | $3.2M | 2.8% | +4.2% | 13F ↗ |
| 3 | iShares Tr Rus 1000 Val Etf | 12,020 | $3.0M | 2.6% | +108% | 13F ↗ |
| 4 | Invesco Exchange Traded Fd T S&P500 Pur Val | 25,447 | $2.9M | 2.6% | +110% | 13F ↗ |
| 5 | VRTX Vertex Pharmaceuticals Incorporated | 5,115 | $2.7M | 2.4% | +2.3% | 13F ↗ |
| 6 | INVH Invitation Homes Inc. | 73,000 | $1.9M | 1.7% | Unchanged | 13F ↗ |
| 7 | AZN AstraZeneca PLC | 11,866 | $1.9M | 1.7% | +4.1% | 13F ↗ |
| 8 | ROIV Roivant Sciences Ltd. | 50,535 | $1.8M | 1.6% | +4.5% | 13F ↗ |
| 9 | INCY Incyte Corporation | 15,140 | $1.8M | 1.6% | +4.8% | 13F ↗ |
| 10 | ARGX argenx SE · ADR | 1,841 | $1.8M | 1.6% | +1.9% | 13F ↗ |
| 11 | NBIX Neurocrine Biosciences, Inc. | 10,230 | $1.5M | 1.3% | +5.2% | 13F ↗ |
| 12 | INSM Insmed Incorporated · Com Par $.01 | 12,195 | $1.4M | 1.2% | +4.2% | 13F ↗ |
| 13 | EEFT Euronet Worldwide, Inc. | 21,560 | $1.4M | 1.2% | +7.8% | 13F ↗ |
| 14 | PTGX Protagonist Therapeutics, Inc. | 9,616 | $1.4M | 1.2% | +4.9% | 13F ↗ |
| 15 | PINE Alpine Income Property Trust, Inc. · Reit | 75,000 | $1.3M | 1.2% | New | 13F ↗ |
| 16 | BLDR Builders FirstSource, Inc. | 22,500 | $1.3M | 1.1% | +80.0% | 13F ↗ |
| 17 | AXSM Axsome Therapeutics, Inc. | 6,752 | $1.2M | 1.1% | +3.4% | 13F ↗ |
| 18 | JAZZ Jazz Pharmaceuticals plc | 4,688 | $1.1M | 1.0% | +29.8% | 13F ↗ |
| 19 | HALO Halozyme Therapeutics, Inc. | 9,821 | $1.1M | 1.0% | +4.2% | 13F ↗ |
| 20 | ASND Ascendis Pharma A/S | 4,706 | $1.1M | 1.0% | +2.6% | 13F ↗ |
| 21 | AMGN Amgen Inc. | 2,455 | $1.0M | 0.9% | +3.9% | 13F ↗ |
| 22 | CTO CTO Realty Growth, Inc. · Reit | 50,000 | $1.0M | 0.9% | +42.9% | 13F ↗ |
| 23 | UMAC Unusual Machines, Inc. | 40,000 | $979.2K | 0.9% | -20.0% | 13F ↗ |
| 24 | ABBV AbbVie Inc. | 3,683 | $963.4K | 0.9% | +1.9% | 13F ↗ |
| 25 | iShares Tr U.S. Real Es Etf | 10,000 | $950.4K | 0.8% | New | 13F ↗ |
| 26 | RYTM Rhythm Pharmaceuticals, Inc. | 9,821 | $935.1K | 0.8% | +3.9% | 13F ↗ |
| 27 | BIIB Biogen Inc. | 4,092 | $924.3K | 0.8% | +5.2% | 13F ↗ |
| 28 | PSNL Personalis, Inc. | 55,854 | $909.3K | 0.8% | -29.2% | 13F ↗ |
| 29 | BFS Saul Centers, Inc. · Reit | 30,000 | $902.4K | 0.8% | -14.3% | 13F ↗ |
| 30 | PNNT PennantPark Investment Corporation | 270,000 | $891.0K | 0.8% | +8.0% | 13F ↗ |
| 31 | ROK Rockwell Automation, Inc. | 2,000 | $870.7K | 0.8% | Unchanged | 13F ↗ |
| 32 | TEM Tempus AI, Inc. | 10,000 | $819.0K | 0.7% | -33.3% | 13F ↗ |
| 33 | CSR D/B/A Centerspace · Reit | 15,000 | $816.0K | 0.7% | +200% | 13F ↗ |
| 34 | J P Morgan Exchange Traded F Betabuldrs Japan | 9,943 | $780.5K | 0.7% | +9.4% | 13F ↗ |
| 35 | XMTR Xometry, Inc. | 7,500 | $771.4K | 0.7% | -25.0% | 13F ↗ |
| 36 | ASML ASML Holding N.V. · Equities | 425 | $770.0K | 0.7% | New | 13F ↗ |
| 37 | GMED Globus Medical, Inc. | 10,000 | $749.0K | 0.7% | Unchanged | 13F ↗ |
| 38 | STXS Stereotaxis, Inc. | 600,000 | $738.0K | 0.7% | Unchanged | 13F ↗ |
| 39 | SYM Symbotic Inc. | 17,500 | $736.2K | 0.7% | +16.7% | 13F ↗ |
| 40 | AVAV AeroVironment, Inc. | 5,162 | $734.1K | 0.7% | +41.4% | 13F ↗ |
| 41 | iShares Inc Msci Aust Etf | 25,625 | $725.4K | 0.6% | +9.2% | 13F ↗ |
| 42 | IONS Ionis Pharmaceuticals, Inc. | 16,163 | $721.7K | 0.6% | +4.8% | 13F ↗ |
| 43 | ISRG Intuitive Surgical, Inc. | 1,750 | $711.6K | 0.6% | Unchanged | 13F ↗ |
| 44 | MANH Manhattan Associates, Inc. | 3,500 | $695.5K | 0.6% | -30.0% | 13F ↗ |
| 45 | KRYS Krystal Biotech, Inc. | 2,046 | $680.4K | 0.6% | +5.2% | 13F ↗ |
| 46 | RDW Redwire Corporation | 65,000 | $678.6K | 0.6% | Unchanged | 13F ↗ |
| 47 | EWTX Edgewise Therapeutics, Inc. | 16,572 | $672.8K | 0.6% | +4.6% | 13F ↗ |
| 48 | ONDS Ondas Inc | 90,000 | $659.7K | 0.6% | Unchanged | 13F ↗ |
| 49 | SNPS Synopsys, Inc. | 1,500 | $652.4K | 0.6% | Unchanged | 13F ↗ |
| 50 | BNTX BioNTech SE · ADR | 6,547 | $643.6K | 0.6% | +4.5% | 13F ↗ |
Showing the top 50 of 245 positions. Premium lists every position, plus puts and calls.
Changes since Q2 2026
34 new, 147 added to, 40 trimmed, 48 exited, 24 unchanged. By estimated dollars.
New positions (34)
| PINE Alpine Income Property Trust, Inc. · Reit | 75,000 | New | $1.3M |
| iShares Tr U.S. Real Es Etf | 10,000 | New | $950.4K |
| ASML ASML Holding N.V. · Equities | 425 | New | $770.0K |
| KNSA Kiniksa Pharmaceuticals International, plc | 7,987 | New | $595.9K |
| OPI Office Properties Income Trust · Com Of Beneficia | 30,000 | New | $477.9K |
| SRRK Scholar Rock Holding Corporation | 9,760 | New | $471.6K |
| IMVT Immunovant, Inc. | 12,276 | New | $414.7K |
| CB Chubb Limited | 1,227 | New | $399.1K |
| DFTX Definium Therapeutics, Inc. | 9,616 | New | $366.0K |
| BEAM Beam Therapeutics Inc. | 14,322 | New | $350.2K |
Added to (147)
| iShares Tr Etf | 66,011 | +410% | $4.3M |
| iShares Tr Rus 1000 Val Etf | 12,020 | +108% | $1.5M |
| Invesco Exchange Traded Fd T S&P500 Pur Val | 25,447 | +110% | $1.5M |
| BLDR Builders FirstSource, Inc. | 22,500 | +80.0% | $570.1K |
| CSR D/B/A Centerspace · Reit | 15,000 | +200% | $544.0K |
| TRV The Travelers Companies, Inc. | 1,767 | +260% | $454.9K |
| CTO CTO Realty Growth, Inc. · Reit | 50,000 | +42.9% | $307.4K |
| JAZZ Jazz Pharmaceuticals plc | 4,688 | +29.8% | $248.9K |
| GL Globe Life Inc. | 3,388 | +79.3% | $248.1K |
| AVAV AeroVironment, Inc. | 5,162 | +41.4% | $214.9K |
Trimmed (40)
| TEM Tempus AI, Inc. | 10,000 | -33.3% | -$409.5K |
| PSNL Personalis, Inc. | 55,854 | -29.2% | -$375.6K |
| GPK Graphic Packaging Holding Company | 5,000 | -88.9% | -$362.0K |
| iShares Tr Jpmorgan Usd Emg | 1,415 | -72.5% | -$339.1K |
| CAH Cardinal Health, Inc. | 558 | -71.7% | -$314.2K |
| T AT&T Inc. | 6,066 | -67.6% | -$308.4K |
| MANH Manhattan Associates, Inc. | 3,500 | -30.0% | -$298.1K |
| XMTR Xometry, Inc. | 7,500 | -25.0% | -$257.1K |
| UMAC Unusual Machines, Inc. | 40,000 | -20.0% | -$244.8K |
| AHRT AH Realty Trust, Inc. | 75,000 | -34.8% | -$244.0K |
Exited (48)
| Apogee Therapeutics Inc | 11,533 | Exited | -$1.5M |
| Invesco Qqq Tr | 1,860 | Exited | -$1.4M |
| Invesco Exch Traded Fd Tr II Nasdaq 100 Etf | 4,518 | Exited | -$1.4M |
| HHH Howard Hughes Holdings Inc. | 15,000 | Exited | -$1.1M |
| SMA SmartStop Self Storage REIT, Inc. | 25,000 | Exited | -$812.5K |
| Catalyst Pharmaceuticals Inc | 23,622 | Exited | -$742.4K |
| AAT American Assets Trust, Inc. · Reit | 30,000 | Exited | -$740.7K |
| AXR AMREP Corporation | 29,060 | Exited | -$732.9K |
| MICC The Magnum Ice Cream Company N.V. | 40,000 | Exited | -$696.4K |
| Nuvalent Inc | 5,558 | Exited | -$686.4K |
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
All positions
Search, sort and filter every position, with puts and calls on their own tab. Premium plan.
Every position, puts and calls. Part of Premium.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Any two quarters side by side. Part of Premium.
Reported value by quarter
Value and number of positions at the end of each quarter.
Loading…
Largest positions in earlier quarters
Pick a quarter to see what the fund's biggest positions were then.
Loading…
Ten largest positions
By value, Q3 2026.
Filings
Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer